<DOC>
	<DOCNO>NCT01121484</DOCNO>
	<brief_summary>A multicenter , 10-week study evaluate efficacy safety 50 mg desvenlafaxine succinate sustained-release formulation ( DVS SR ) versus placebo treatment peri- postmenopausal woman major depressive disorder</brief_summary>
	<brief_title>Study Evaluating Desvenlafaxine Succinate Sustained-Release ( DVS SR ) In The Treatment Of Peri- And Postmenopausal Women With Major Depressive Disorder ( DVS 3364 )</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<mesh_term>Desvenlafaxine Succinate</mesh_term>
	<criteria>Peri postmenopausal woman age 40 70 year fluent write spoken English . Postmenopausal status define 12 consecutive month spontaneous amenorrhea ; le 12 consecutive month least 6 consecutive month spontaneous amenorrhea prebaseline folliclestimulating hormone ( FSH ) level &gt; 40 mIU/mL ; 6 month postsurgical bilateral oophorectomy ( without hysterectomy ) . Perimenopausal woman define presence follow within 6 month baseline : 1. absolute change 7 day menstrual cycle length within 6 month baseline ; 2. change menstrual flow amount ( 2 flow category , eg , light moderately light moderately heavy heavy ) ; 3. change duration ( absolute change 2 day ) ; 4. period amenorrhea last least 3 month . A primary diagnosis major depressive disorder ( MDD ) base criterion Diagnostic Statistical Manual Mental Disorders , Fourth EditionText Revision ( DSMIVTR ) , single recurrent episode , without psychotic feature use modify Mini International Neuropsychiatric Interview ( MINI ) . A Montgomery Asberg Depression Rating Scale ( MADRS ) total score &gt; =25 screen baseline ( day 1 ) visit 5point improvement screen baseline . Treatment DVS SR ( Pristiq® ) time past and/or venlafaxine , ie , Effexor® Effexor XR® , 1 year prior baseline . Treatmentresistant ; eg , past 3 year follow treatment fail : ( ) 3 previous adequate trial &gt; =2 class antidepressant medication , ( b ) electroconvulsive therapy , ( c ) 2 adequate trial psychotherapy ( eg , behavior therapy , behaviormarital therapy ) . History current evidence gastrointestinal disease know interfere absorption excretion drug history surgery know interfere absorption excretion drug . Known presence raise intraocular pressure history narrowangle glaucoma .</criteria>
	<gender>Female</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>